Decreased anterior cingulate myo-inositol/creatine spectroscopy resonance with lithium treatment in children with bipolar disorder

Neuropsychopharmacology

Volumn 24, Issue 4, 2001, Pages 359-369

  Davanzo, Pablo ^a,d   Thomas, M Albert ^b   Yue, Kenneth ^b   Oshiro, Thomas ^b   Belin, Thomas ^c   Strober, Michael ^a   McCracken, James ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Hypomania; Lithium; Magnetic resonance spectroscopy; Mania; Pre adolescents

Indexed keywords

CARBAMAZEPINE; CHOLINE; CREATINE; DEXAMPHETAMINE; INOSITOL; LITHIUM; OLANZAPINE; PIMOZIDE; RISPERIDONE; THIORIDAZINE; VALPROATE SEMISODIUM;

ADOLESCENT; AGE DISTRIBUTION; AREA UNDER THE CURVE; ARTICLE; CINGULATE GYRUS; CLINICAL ARTICLE; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG TISSUE LEVEL; FEMALE; HUMAN; MALE; MANIC DEPRESSIVE PSYCHOSIS; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SCHOOL CHILD; SEX DIFFERENCE; SINGLE BLIND PROCEDURE;

ADOLESCENT; AREA UNDER CURVE; ASPARTIC ACID; BIPOLAR DISORDER; CHILD; CREATINE; DEMOGRAPHY; DRUG ADMINISTRATION SCHEDULE; FEMALE; GYRUS CINGULI; HUMANS; INOSITOL; LITHIUM; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; PROTONS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 0035137636     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(00)00207-4     Document Type: Article

References (55)

1. Inositol monophosphatase - A putative target for Li+ in the treatment of bipolar disorder
2. Lithium amplifies agonist-dependent phosphatidylinositol responses in brain and salivary glands
3. Attention-deficit hyperactivity disorder and juvenile mania: An overlooked comorbidity?
4. CBCL clinical scales discriminate prepubertal children with structured interview-derived diagnosis of mania from those with ADHD
5. Predictors of response to divalproex and lithium
6. Elevated platelet membrane phosphatidylinositol-4,5-bisphosphate in bipolar mania
7. Predictors of response to mood stabilizers
8. Lithium in hospitalized children at 4 and 8 weeks: Mood, behavior and cognitive effects
9. The Great Smoky Mountains Study of Youth. Goals, design, methods, and the prevalence of DSM-III-R disorders
10. Anatomic and behavioral aspects of frontal-subcortical circuits
11. Disruption by lithium of phosphoinositide signalling in cerebellar granule cells in primary culture
12. Contributions of anterior cingulate cortex to behaviour
13. Psychopharmacologic treatment of pathologic aggression
14. Altered platelet protein kinase C activity in bipolar affective disorder, manic episode
15. Synopsis of function and dysfunction of the frontal lobe
16. Double-blind and placebo-controlled study of lithium for adolescent bipolar disorders with secondary substance dependency
17. Child and adolescent bipolar disorder: A review of the past 10 years
18. Abnormal facial emotion recognition in depression: Serial testing in an ultra-rapid-cycling patient
19. Quantitative MRI of the temporal lobe, amygdala, and hippocampus in normal human development: Ages 4-18 years
20. Measurement of human brain lithium in vivo by MR spectroscopy
21. Sources of lithium resistance in mixed mania
22. Lithium-resistant adolescent mania
23. Choline-containing compounds detected by proton magnetic resonance spectroscopy in the basal ganglia in bipolar disorder
24. Brain lithium concentrations measured with lithium-7 magnetic resonance spectroscopy in patients with affective disorders: Relationship to erythrocyte and serum concentrations
25. Lateralized abnormality of high energy phosphate metabolism in the frontal lobes of patients with bipolar disorder detected by phase-encoded 31P-MRS
26. Anterior paralimbic mediation of procaine-induced emotional and psychosensory experiences
27. Development of the human brain: In vivo quantification of metabolite and water content with proton magnetic resonance spectroscopy
28. Bipolar disorders in a community sample of older adolescents: Prevalence, phenomenology, comorbidity, and course
29. Modulation of protein kinase C isozymes and substrates by lithium: The role of myo-inositol
30. Reciprocal limbic-cortical function and negative mood: Converging PET findings in depression and normal sadness
31. A review of chemical issues in 1H NMR spectroscopy: N-acetyl-L-aspartate, creatine and choline
32. Temporal dissociation between lithium-induced changes in frontal lobe myo-inositol and clinical response in manic-depressive illness
33. Regulation of inositol monophosphatase in Saccharomyces cerevisiae
34. Structural and functional brain changes in bipolar disorder: A selective review
35. A depression rating scale for children
36. Temporal lobe proton magnetic resonance spectroscopy of patients with first-episode psychosis
37. Discussing hidden bias in observational studies
38. Subclinical hepatic encephalopathy: Proton MR spectroscopic abnormalities
39. Mood stabilizers in children and adolescents
40. Variability of brain lithium levels during maintenance treatment: A magnetic resonance spectroscopy study
41. Proton magnetic resonance spectroscopy of the brain in schizophrenic and affective patients
42. The Mini-International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10
43. Chronic lithium does not alter human myo-inositol or phosphomonoester concentrations as measured by 1H and 31P MRS
44. Platelet membrane phospholipids in euthymic bipolar disorder patients: Are they affected by lithium treatment?
45. Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): The CGI-BP
46. Erythrocyte choline concentration in bipolar disorder: A predictor of clinical course and medication response
47. Brain magnetic resonance imaging of structural abnormalities in bipolar disorder
48. Recovery and relapse in adolescents with bipolar affective illness: A five-year naturalistic, prospective follow-up
49. Depression during mania. Treatment response to lithium or divalproex
50. Lithium treatment and risk of suicidal behavior in bipolar disorder patients
51. Subtypes of aggression and their relevance to child psychiatry
52. Structural organization of cingulate cortex: Areas, neurons, and somatodendritic receptors
53. Bipolar disorder in children: Misdiagnosis, underdiagnosis, and future directions
54. A rating scale for mania: Reliability, validity and sensitivity